首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Lymphokine and phorbol (PMA) regulation of complement (C2) synthesis using U937
Authors:Bruch H Littman  Robert E Hall  Andrew V Muchmore
Institution:1. Division of Immunology and Connective Tissue Diseases, Medical College of Virginia and the McGuire VA Medical Center, Richmond, Virginia USA;2. Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205 USA
Abstract:Human monocytes synthesize large amounts of the second complement component (C2) after incubation with a T-lymphocyte product called monocyte complement stimulator (MCS). The human monocyte-like cell line, U937, also synthesizes C2 and can be stimulated to increase this synthesis by lymphokine-rich culture supernates. Additionally, phorbol myristate acetate (PMA), an agent which induces maturational changes in other macrophage-like cell lines, also stimulates C2 synthesis by U937 cells. Lymphokine and PMA stimulation of C2 secretion by U937 are both reversibly inhibitable by cycloheximide. At optimal concentrations for stimulation of C2 synthesis, PMA inhibits 3H]thymidine incorporation by U937 indicating that increased C2 is not due to increased numbers of U937 cells.
Keywords:To whom all correspondence should be addressed: McGuire VA Medical Center  Medical Service (111)  Rheumatology Section  Richmond  Va  23249  
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号